These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30341286)

  • 1. Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
    Zhou X; Zang X; Guan Y; Tolbert T; Zhao TC; Bayliss G; Zhuang S
    Cell Death Dis; 2018 Oct; 9(11):1067. PubMed ID: 30341286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
    Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
    Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling.
    Liang H; Huang Q; Liao MJ; Xu F; Zhang T; He J; Zhang L; Liu HZ
    Inflamm Res; 2019 Apr; 68(4):325-336. PubMed ID: 30820607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model.
    Liu H; Chen Z; Weng X; Chen H; Du Y; Diao C; Liu X; Wang L
    FASEB J; 2020 Jan; 34(1):835-852. PubMed ID: 31914694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.
    Wen L; Tao SH; Guo F; Li LZ; Yang HL; Liang Y; Zhang LD; Ma L; Fu P
    Acta Pharmacol Sin; 2022 Aug; 43(8):2067-2080. PubMed ID: 34937916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.
    Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S
    Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.
    Zhou X; Zang X; Ponnusamy M; Masucci MV; Tolbert E; Gong R; Zhao TC; Liu N; Bayliss G; Dworkin LD; Zhuang S
    J Am Soc Nephrol; 2016 Jul; 27(7):2092-108. PubMed ID: 26701983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Omics Integrated Analysis of the Protective Effect of EZH2 Inhibition in Mice with Renal Ischemia-Reperfusion Injury.
    Zou S; Chen J; Zhou P; Xue M; Wu M; Wang L
    Kidney Blood Press Res; 2024; 49(1):196-207. PubMed ID: 38368866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
    Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
    Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
    Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of EZH2 ameliorates hyperoxaluria-induced kidney injury through the JNK/FoxO3a pathway.
    Gao X; Peng Y; Fang Z; Li L; Ming S; Dong H; Li R; Zhu Y; Zhang W; Zhu B; Liao J; Wang Z; Liu M; Li W; Zeng J; Gao X
    Life Sci; 2022 Feb; 291():120258. PubMed ID: 34952043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.
    Wan SS; Pan YM; Yang WJ; Rao ZQ; Yang YN
    FASEB J; 2020 Aug; 34(8):10168-10181. PubMed ID: 32562311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Function of Interleukin-1β-Induced Neutrophil Gelatinase-Associated Lipocalin in Renal Tubular Cells.
    Konno T; Nakano R; Mamiya R; Tsuchiya H; Kitanaka T; Namba S; Kitanaka N; Okabayashi K; Narita T; Sugiya H
    PLoS One; 2016; 11(11):e0166707. PubMed ID: 27851800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 16. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
    Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
    Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3.
    Liebisch M; Wolf G
    Am J Nephrol; 2020; 51(9):676-692. PubMed ID: 32854097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Duraisamy AJ; Mishra M; Kowluru RA
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 inhibitor DZNep modulates microglial activation and protects against ischaemic brain injury after experimental stroke.
    Chen J; Zhang M; Zhang X; Fan L; Liu P; Yu L; Cao X; Qiu S; Xu Y
    Eur J Pharmacol; 2019 Aug; 857():172452. PubMed ID: 31202798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice.
    Zhou D; Li Y; Lin L; Zhou L; Igarashi P; Liu Y
    Kidney Int; 2012 Sep; 82(5):537-47. PubMed ID: 22622501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.